Women dread pelvic exams and have for almost 200 years since the speculum was invented in 1845. The reason for this is simple: speculums are tremendously uncomfortable, particularly in the hands of an inexperienced physician. Companies have tried for years to design a more humane speculum with mixed results. Only recently have innovators and inventors pushed back and asked: Why don’t we try something entirely different?
There are plenty more examples. Femtech entrepreneurs—buoyed by technology—have decided that many medical solutions must be completely reimagined, not just redesigned. Part of the problem is systemic inequities and healthcare’s resistance to change, even though women are the biggest consumers of health and wellness solutions in the U.S., spending billions more than men annually. As a result of the current shortcomings in women’s healthcare and a burgeoning demand, a new generation of designers and technologists is taking the initiative.
I believe femtech has enormous potential to improve women’s health outcomes and overcome persistent socioeconomic and geographical barriers that inhibit access to health care. Here are three ways femtech—powered by ingenious design—is revolutionizing health care.
IT’S ABOUT REIMAGINING HEALTHCARE, NOT REDESIGNING
There has been a dearth of innovation in women’s health for decades. Historians have even studied how historical injustice and inequity shaped women’s health care and paved the road to many problems women still face in 2024. Women are still subjected to invasive and controversial tests and treatments that have significant risks. Femtech is changing this. Just a few examples include:
- Breast Cancer Screening: Instead of redesigning the mammogram, femtech pioneers have created new diagnostic aids for detecting breast cancer that use tears (Namida) and an AI-driven portable 3D breast ultrasound scanner to pinpoint the lesion (iSono, part of my company’s Femovate program).
- Uterine Fibroid Treatment: Instead of surgery that can cause infertility, Nesa Medtech, also part of the Femovate program, has come up with a new scarless solution to remove uterine fibroids.
- Ovarian Cancer Screening: Instead of detecting ovarian cancer at the most advanced stages (70%-80% of ovarian cancer is already at stage III or IV), OvaWatch’s non-invasive blood test can screen for ovarian cancer risk.
- Same-Day IUD: Instead of two to three visits to get a hormonal IUD, Medicines360 created a same-day solution, AVIBELA, to improve timely access to reproductive care, and reduce the burden on women in healthcare deserts and those facing financial and transportation challenges.
IT’S ABOUT PROVIDING PROACTIVE VERSUS REACTIVE CARE
When patients and providers act proactively, the upsides are enormous. Diseases like cancer can be caught early and prevented (colon cancer rates, for example, have plummeted since screenings like the colonoscopy became commonplace). Chronic conditions like diabetes and hypertension can be managed with proactive care (studies show that proactive diabetes care reduces complications).
But women’s preventative care solutions are still lagging. Many women suffer for years with underdiagnosed or misdiagnosed conditions, or are discharged from the ER and told their chest pain is anxiety or that their preeclampsia symptoms are gas. Without preventative care, these conditions worsen, leading to reactive, emergency care situations and even death. Femtech is actively driving innovation for proactive care, including detection and interventions for:
- Preterm Labor: Identifying the risk of preterm labor before it happens (Pregnolia) and offering solutions other than bed rest (Novocuff).
- Postpartum Hemorrhage: Another company in the Femovate program, Armor Medical, is proactively detecting postpartum hemorrhage.
- Postpartum Depression: Determining women’s risk for mental health disorders before delivery (Dionysus Digital Health).
- Ovarian Aging: Delaying ovarian aging and reducing the occurrence of diseases and chronic conditions as women age (Garrison Lab).
IT’S ABOUT EMPOWERING VERSUS DISEMPOWERING FEMALE PATIENTS
One of the biggest obstacles women face in the healthcare system is that they aren’t heard, and their concerns are trivialized (I looked into this in my story on spite tracking). Femtech tracking tools and at-home testing kits empower women with education and actionable data about their health conditions and treatment options. The biggest innovations in this space include:
- At-Home Endometriosis Tests: Instead of the average eight to ten years to receive an endometriosis diagnosis, women will soon be able to screen at home and have an answer in weeks (Afynia and Endometrics).
- At-Home Perimenopause Test: Proov’s Empower, part of the Femovate program, allows women to test accurately to discover their stage of menopause, as well as track symptoms.
- At-Home Pelvic Health Care: Physical therapy appointments can now be supplemented with Evvy or Perifit for strengthening the pelvic floor, Hyivy’s pelvic floor rehabilitation system, or Happy Sneeze’s digital program for reducing incontinence.
GOODBYE TO THE SPECULUM
Women should no longer settle for medical tools, tests, and routines that are antiquated, invasive, or cause irreparable damage. The McKinsey Health Institute report shows that providing better care and support for women globally could add up to a $1 trillion increase in economic productivity, and a recent report from the World Health Organization shows digital health solutions are effectively helping many women manage pregnancy, menstruation, and mental health.
The dreaded speculum? It’s on the way out, albeit slowly. Femtech companies have found ways to accurately screen and diagnose cervical cancer with an at-home kit (Thyia) and a patch (Curiva). As femtech continues to innovate, plenty of these outdated legacy practices and tools will be replaced by solutions that keep women healthy and empower them.